Exchange Traded Concepts LLC Holds Stock Position of $370,000 in PetMed Express,
December 23, 2022
Trending News 🌥️
PETMED ($NASDAQ:PETS): PetMed Express, Inc. is a leading pet pharmacy in the United States. It provides prescription and non-prescription pet medications, health products and supplies for dogs and cats. It operates through its website and call centers and offers free shipping on all orders. Exchange Traded Concepts LLC is a registered investment advisor that provides a range of services to its clients, including portfolio management, research and analysis, and corporate finance consulting.
The company’s investment portfolio includes stocks, bonds, mutual funds, real estate, and other alternative investments. It has a long history of investing in PetMed Express, Inc., and holds a significant share of the company’s stock.
Stock Price
The stock opened at $18.0 and closed at $17.7, representing a 3.0% decrease from its previous closing price of 18.2. PetMed Express is an online pet pharmacy that sells prescription and non-prescription pet medications, health products, and supplies. PetMed Express provides medications for dogs, cats, and other species of pets. The company specializes in exchange-traded funds (ETFs), which are investments that trade on stock exchanges like stocks.
Investors may find the news encouraging as it suggests that the company is in a strong financial position. Analysts and investors will be closely monitoring PetMed Express’s stock performance in the coming weeks to see if it will recover from its recent dip. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Petmed Express. More…
| Total Revenues | Net Income | Net Margin |
| 262.3 | 15.68 | 6.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Petmed Express. More…
| Operations | Investing | Financing |
| 22.53 | -8.12 | -24.43 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Petmed Express. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 169.26 | 31.11 | 6.55 |
Key Ratios Snapshot
Some of the financial key ratios for Petmed Express are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -1.5% | -16.2% | 7.1% |
| FCF Margin | ROE | ROA |
| 7.4% | 8.4% | 6.9% |
VI Analysis
PETMED EXPRESS is a medium risk investment according to the VI Risk Rating. This rating is based on the company’s fundamentals, which reflect its long-term potential. This includes financial and business aspects, such as revenue, cash flow, debt and more. The VI App has detected two risk warnings related to PETMED EXPRESS’ income sheet and balance sheet. This means that investors should be aware of potential risks associated with investing in the company. Investors should also consider other factors when making an investment decision, such as the company’s competitive landscape, its management, and the overall market conditions. Additionally, investors should do their own research before investing in order to ensure that their investment is sound and in line with their goals. Overall, PETMED EXPRESS is a medium risk investment and investors should take the time to assess all relevant information before investing. They should also register on the VI App to access the latest risk warnings related to their desired investment. More…
VI Peers
PetMed Express Inc is one of the largest online pet pharmacies in the United States. The company offers a wide range of pet medications, supplies, and products at competitive prices. PetMed Express also offers a wide variety of services, including prescription refill reminders, online pet health information, and a pet health hotline. The company’s main competitors are Oriola Corp, Trxade Health Inc, Yunnan Jianzhijia Health-Chain Co Ltd.
– Oriola Corp ($LTS:0NER)
Oriola Corporation is a Finnish company that provides branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company has a market capitalization of €330.77 million and a return on equity of 7.73%. Oriola Corporation is a leading provider of branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company offers a wide range of products and services, including branded pharmaceuticals, generic pharmaceuticals, over-the-counter (OTC) products, medical devices, and services.
– Trxade Health Inc ($NASDAQ:MEDS)
Trxade Health Inc is a healthcare company that focuses on providing services and products to the healthcare industry. The company has a market cap of 8.16M as of 2022 and a Return on Equity of -110.47%. Trxade Health Inc’s main products and services include healthcare software and services, medical supplies, and pharmaceuticals. The company operates in the United States and Canada.
– Yunnan Jianzhijia Health-Chain Co Ltd ($SHSE:605266)
Yunnan Jianzhijia Health-Chain Co Ltd is a Chinese company that focuses on the development and application of health-related big data technology. The company’s products and services include a health information platform, a health data application platform, and a health management platform. As of 2022, Yunnan Jianzhijia Health-Chain Co Ltd has a market cap of 5.46B and a Return on Equity of 11.7%.
Summary
Investing in PetMed Express, Inc. (NASDAQ: PETS) can be an attractive option for those interested in the healthcare sector. The company specializes in providing pet medications, supplies, and other related services to pet owners through a variety of channels, including online and by mail order. One of the key advantages of investing in PetMed Express is that it is a relatively low-risk investment.
Additionally, the company has a strong balance sheet and has been profitable for many years. This stability makes it an ideal choice for those with a conservative approach to investing. Another factor to consider when investing in PetMed Express is the potential for capital appreciation. The company’s stock price has been steadily increasing over the past several years and could continue to do so as the company continues to expand its market share and increase its revenues. Additionally, the company pays a modest dividend, which can provide investors with a steady stream of income. Finally, PetMed Express is well-positioned to take advantage of current trends in the healthcare industry. The pet healthcare market, in particular, is growing rapidly, driven by rising pet ownership and an aging population. With its strong brand and excellent customer service, PetMed Express should be well-positioned to capitalize on these trends. Therefore, investors interested in the healthcare sector should consider investing in PetMed Express as part of their portfolio.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
